Harvard Bioscience (HBIO) Shareholder's Equity (2010 - 2026)
Harvard Bioscience (HBIO) Shareholder's Equity (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 17.60 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 24.13 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 11.27 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 6.49 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 2.99 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 4.97 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 8.24 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 4.15 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 6.02 Bn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | 10.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.05 Mn |
| Dec 31, 2025 | 13.73 Mn |
| Sep 30, 2025 | 14.07 Mn |
| Jun 30, 2025 | 15.73 Mn |
| Mar 31, 2025 | 14.84 Mn |
| Dec 31, 2024 | 63.34 Mn |
| Sep 30, 2024 | 65.32 Mn |
| Jun 30, 2024 | 67.25 Mn |
| Mar 31, 2024 | 68.81 Mn |
| Dec 31, 2023 | 73.07 Mn |
| Sep 30, 2023 | 74.29 Mn |
| Jun 30, 2023 | 75.39 Mn |
| Mar 31, 2023 | 74.34 Mn |
| Dec 31, 2022 | 72.22 Mn |
| Sep 30, 2022 | 71.98 Mn |
| Jun 30, 2022 | 77.50 Mn |
| Mar 31, 2022 | 76.38 Mn |
| Dec 31, 2021 | 83.40 Mn |
| Sep 30, 2021 | 76.89 Mn |
| Jun 30, 2021 | 78.70 Mn |